Company Search:
Advanced Search
Sponsored Links
Essex Bio-Technology Limited Company Snapshot
Essex Bio-Technology Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Essex Bio-Technology Limited with three other pharmaceutical manufacturers in Asia: Panacea Biotec Ltd of India (2016 sales of 6.53 billion Indian Rupees [US$102.01 million] of which 59% was Formulation), Pulike Biological Engineering Inc of China (583.09 million Chinese Renmimbi [US$90.48 million] of which 93% was Veterinary Chemicals), and Walvax Biotechnology Company Limited which is also based in China (590.16 million Chinese Renmimbi [US$91.58 million] of which 38% was Autonomous Vaccine).

Sales Analysis. Essex Bio-Technology Limited reported sales of HK$775.66 million (US$99.15 million) for the year ending December of 2016. This represents an increase of 18.6% versus 2015, when the company's sales were HK$654.01 million. Sales at Essex Bio-Technology Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 265%). Sales of Sales of Pharmaceutical Products saw an increase of 20.7% in 2016, from HK$602.84 million to HK$727.82 million. Not all segments of Essex Bio-Technology Limited experienced an increase in sales in 2016: sales of Other Businesses fell 6.5% to HK$47.85 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Essex Bio-Technology Limited
  Stock Performance Chart for Essex Bio-Technology Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 5.62
(Figures in Hong Kong Dollars)
1 Week 21.4%   13 Weeks 19.6%  
4 Weeks 11.5%   52 Weeks 63.8%  
Essex Bio-Technology Limited Key Data:
  Ticker: 1061 Country: Hong Kong
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 775,662,998
(Year Ending Jan 2017).
Employees: 966
  Currency: Hong Kong Dollars Market Cap: 3,165,656,080
  Fiscal Yr Ends: December Shares Outstanding: 563,284,000
  Share Type: Ordinary Closely Held Shares: 303,714,117
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.